As of 2025-06-20, the Fair Value of Crescita Therapeutics Inc (CTX.TO) is -0.80 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.51 CAD, the upside of Crescita Therapeutics Inc is -257.60%.
With the market price of 0.51 CAD and our fair value calculation, Crescita Therapeutics Inc (CTX.TO) is not a good investment. Investing in CTX.TO stocks now will result in a potential loss of 257.60%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | 0.04 | -1.11 | 0.86 | -1.99 | -2.75 | -0.99 |
| YoY growth | -97.85% | -2,875.00% | 177.48% | -330.93% | -38.47% | -632.95% |
| Market Cap (mil) | 9.70 |
| P/E | |
| Forward P/E |
| EPS | -0.16 |
| Avg earnings growth rate | -632.95% |
| TTM earnings | -3.06 |